Thus, the alterations in these processes observed by downregulation of the mitochondrial fusion-related proteins Mfn-2 and Opa-1 and an upregulation of the fission protein Fis-1 in PBMCs from BD patients (128) might explain the abnormal mitochondrial morphology and distribution findings in patients with BD
These include: Calorie restriction Nutritional deficiencies Protein deficiences Physiological stress These changes are interlinked
Control over: Where your medication is What temperature its exposed to How its stored Because once you control those elements, everything else becomes secondary
Keep out of reach of children
Liquid chromatography-mass spectrometry was performed using a Waters Acquity Premier UPLC system coupled to a SELECT SERIES Cyclic IMS, which combines a Q-Tof (Quadrupole-Time of Flight) mass spectrometer with cIM (Cyclic Ion Mobility) (Waters, Milford, MA), operated in positive electrospray ionization mode
Syal C, Wang J (2021) Biomarker-guided drug therapy:personalized medicine for treating Alzheimer's disease